Programs
BrainGate consortium, two programs
Updated 1 Feb 2026BrainGate2 clinical trial (speech neuroprosthesis)Clinical trial using implanted electrode arrays to decode intended speech from motor cortex and convert to synthesized speech.DeployNextUC Davis speech trial recruiting · Aug 2022Updated 1 Feb 2026View program →BrainGate2 robotic arm controlBrainGate2 track demonstrating decoded motor control of robotic arms for reaching and grasping by tetraplegia patients.DeployNextBrainGate3 home-use trial begins · 2026Updated 1 May 2012View program →
Research · Proto · Pilot · Deploy · Scaling
Upcoming catalysts
- 2027Neurorehabilitation outcomes from participantsBrainGate2 clinical trial (speech neuroprosthesis)by ~15 mo
- 2027FDA breakthrough device designation for speech BCIBrainGate2 clinical trial (speech neuroprosthesis)by ~15 mo
- 2027Rice/Baylor BrainGate3 home study resultsBrainGate2 robotic arm controlby ~15 mo
- 2027Commercial robotic arm BCI integrationBrainGate2 robotic arm controlby ~15 mo
Peers
- NeuralinkN1 implant (Telepathy)Pilot$9Bprivate
- AxoftFleuron ultrasoft iBCIPilot$300Mprivate
- NeuroXessXessCorePilot$100Mprivate
- Echo NeurotechnologiesSpeech BCI (Cortical Surface, Avatar Speech)Pilot—
- Blackrock NeurotechUtah array / NeuroPortPilot—
- NeuracleNEO Implantable Brain-Computer InterfaceDeploy—
- StairMedImplanted BCI (Ultra-flexible Electrodes)Pilot—
- ParadromicsConnexus BCIPilot—
Company & funding
- HQ
- US
People
- Leigh HochbergDirector
- David Brandmanresearcher
- Sergey Staviskyresearcher